Scheduling of Gabapentin The 2019 Virginia General Assembly passed HB2557 which classifies gabapentin as a Schedule V controlled substance as of July 1, 2019. Until then, gabapentin remains a drug of concern classified as a Schedule VI controlled substance. On July 1, 2019, veterinary establishments that possess gabapentin must take a complete and accurate inventory of this drug at the opening § 54.1-3454. Schedule V. The controlled substances listed in this section are included in Schedule V: 1. Any compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, which also contains one or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation, valuable medicinal qualities Types of Schedule V Drug Charges Schedule V drug charges under Virginia law include offenses involving the distribution, manufacture, or possession of these drugs. Lawmakers in Virginia have changed several of the controlled substance laws. However, a conviction can still carry severe consequences, including mandatory minimum prison terms. One study noted an increase in overdose deaths involving gabapentin as recorded in the State Unintentional Drug Overdose Reporting System, which tracks drug overdoses in 23 states, including West Virginia. 4 The investigators did not, however, break down the data at the state level. We would like to show you a description here but the site won’t allow us. Gabapentin, a Schedule V drug in the Commonwealth, had previously been considered a “drug of concern” in Virginia. The 2019 Virginia General Assembly passed HB2557, which classified gabapentin as a Schedule V controlled substance as of July 1, 2019. But several states consider gabapentin a schedule V (schedule 5) controlled substance. In states where gabapentin is a controlled substance, there’s stricter laws regarding prescribing and dispensing it from pharmacies. §60A-2-212. Schedule V. (a) Schedule V shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. As an example, Virginia passed a law in 2019 to classify gabapentin as a Schedule V controlled substance. This means Virginia pharmacies must comply with the state’s controlled substance laws when dispensing and refilling gabapentin prescriptions. As an example, Virginia passed a law in 2019 to classify gabapentin as a Schedule V controlled substance. This means Virginia pharmacies must comply with the state’s controlled substance laws when dispensing and refilling gabapentin prescriptions. Legal Implications of Gabapentin’s Status The classification of gabapentin as a Schedule V substance in Virginia carries significant legal implications for healthcare providers, pharmacists, and patients. By placing gabapentin under this schedule, the state mandates that it be dispensed only with a prescription. § 54.1-3450. Schedule III. The controlled substances listed in this section are included in Schedule III: 1. Unless specifically exempted or listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system: Any substance which contains any quantity of a derivative of HB2557: Drug Control Act; classifies gabapentin as a Schedule V controlled substance. § 54.1-3455. Schedule VI. The following classes of drugs and devices shall be controlled by Schedule VI: 1. Any compound, mixture, or preparation containing any stimulant or depressant drug exempted from Schedules III, IV or V and designated by the Board as subject to this section. 2. We compared two interventions including (1) class V scheduling of gabapentin and (2) gabapentin inclusion in the state PDMP using a control group of similar states. The Schedule V change for gabapentin was implemented in three states including Kentucky, Tennessee, and West Virginia (Table 1). Code of Virginia Table of Contents » Title 54.1. Professions and Occupations » Subtitle III. Professions and Occupations Regulated by Boards within the Department of Health Professions » Chapter 34. Drug Control Act » Article 5. Standards and Schedules » § 54.1-3446. Schedule I Section Print PDF email Code of Virginia Table of Contents » Title 54.1. Professions and Occupations » Subtitle III. Professions and Occupations Regulated by Boards within the Department of Health Professions » Chapter 34. Drug Control Act » Article 5. Standards and Schedules » § 54.1-3452. Schedule IV Section Print PDF email Drug Control Act; Schedule V; gabapentin. Classifies gabapentin as a Schedule V controlled substance. Current law lists gabapentin as a drug of concern. The bill also removes the list of drugs of concern from the Code of Virginia and provides that any wholesale drug distributor licensed and regulated by the Board of Pharmacy and registered with and regulated by the U.S. Drug Enforcement Gabapentin is a prescription medication approved by the FDA for the treatment of neuropathic pain (postherpetic neuralgia) and seizure disorders. Why is gabapentin controlled in some states? Gabapentin is structurally and pharmacologically related to pregabalin (Lyrica, Lyrica CR), which is a Schedule V drug and controlled federally in all states. The 2019 Virginia General Assembly recently passed a new bill that will classify gabapentin as a Schedule V substance starting July 1, 2019. Currently, gabapentin is classified as a Schedule VI drug of concern. This change in schedule will require gabapentin to be reported to the Virginia Prescription Monitoring Program as a schedule V substance.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |